A Whole Exon Screening-Based Score Model Predicts Prognosis and Immune Checkpoint Inhibitor Therapy Effects in Low-Grade Glioma.
Front Immunol
; 13: 909189, 2022.
Article
de En
| MEDLINE
| ID: mdl-35769464
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Tumeurs du cerveau
/
Gliome
Type d'étude:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limites:
Humans
Langue:
En
Journal:
Front Immunol
Année:
2022
Type de document:
Article
Pays d'affiliation:
Chine